Romine, Kyle A. http://orcid.org/0000-0003-3757-7690
MacPherson, Kevin
Cho, Hyun-jun
Kosaka, Yoko
Flynn, Patrick A.
Byrd, Kaelan H.
Coy, Jesse L.
Newman, Matthew T. http://orcid.org/0000-0002-2091-8869
Pandita, Ravina http://orcid.org/0000-0001-6110-6608
Loo, Christopher P.
Scott, Jaime
Adey, Andrew C.
Lind, Evan F. http://orcid.org/0000-0001-7026-2012
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (5T15LM7088-28)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM124704)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R01CA262145-01A1, U54CA224019, U01CA217862)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 26 May 2022
Revised: 8 December 2022
Accepted: 4 January 2023
First Online: 21 January 2023
Competing interests
: EFL has received research funding from Janssen, Celgene, Monojul, Ikena Oncology, Kronos Bio, Intellia Therapeutics and Amgen. The rest of the authors declare no competing interests.